Stockreport

340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program's Goals [Forbes]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF On November 12, 2024, Johnson & Johnson took a bold step by filing a lawsuit against the Health Resources and Services Administration over the 340B Drug Pricing Program [Read more]